Role of Meda (Adipocyte) in Yakrit Vikara (liver diseases) - Ayurveda prospective

Dr. Ashok Kumar Panda; Guru Charan Bhuyan; Krishna Rao; Binitha P; Susmita Otta; Kamala Kanta Parhi

doi:10.21760/jaims.v5i02.876

Dr. Ashok Kumar Panda Research Officer, Central Ayurveda Research Institute of Hepatobiliary Disorders, Bharatpur, Bhubaneswar, Odisha, INDIA.
Guru Charan Bhuyan Research Officer, Central Ayurveda Research Institute of Hepatobiliary Disorders, Bharatpur, Bhubaneswar, Odisha, INDIA.
Krishna Rao Research Officer, Central Ayurveda Research Institute of Hepatobiliary Disorders, Bharatpur, Bhubaneswar, Odisha, INDIA.
Binitha P Research Officer, Central Ayurveda Research Institute of Hepatobiliary Disorders, Bharatpur, Bhubaneswar, Odisha, INDIA.
Susmita Otta Research Officer, Central Ayurveda Research Institute of Hepatobiliary Disorders, Bharatpur, Bhubaneswar, Odisha, INDIA.
Kamala Kanta Parhi Assistant Professor, Department of Bio chemistry, Lord Buddha Koshi Medical College and Hospital, Saharsa, Bihar, INDIA.

DOI: https://doi.org/10.21760/jaims.v5i02.876

Keywords: Adipose Tissue, Durmeda, Fatty Liver, Medadhatu, Yakritdalludara, Yakrimeda

Abstract

Meda Dhatu (Adipose tissue) was considered as inert tissue that stores fat only but now it is an endocrine gland which controls coagulation, appetite regulation, immunity, glucose and lipid metabolism, reproduction, angiogenesis, fibrinolysis, body weight homeostasis and vascular tone control. Meda is the fourth Dhatu (stable constituent of body) as per Ayurveda doctrine and resemble with the adipose tissue. Meda can create not only Sthyaulya (Obesity) in general but also organ specific disorders like - Medaja Granthi , Medaja Masurika, Medaja Galaganda, Medaja Vridhi etc. Yakritmeda is found in Sanskrit literature. But Medaja Yakritdalludara or Yakrit Vikar is not enumerated in classical Ayurveda literature. Strong evidences suggested that accumulation of lipids in non-adipose tissues can contribute to cellular dysfunction and cell death, a phenomenon that is called lipotoxicity. Various components of Meda and its function found in Ayurveda literature are discussed. Multiple factors hit hypothesis for Samprapti (pathogenesis) of Medaja Yakrut Vikara (Fatty liver disorders) and its progression with preventive and curative strategies are described with scientific evidences.

Downloads

Download data is not yet available.

References

Andreas, Holger, "Theoretical Terms in Science", The Stanford Encyclopedia of Philosophy (Fall 2017 Edition), Edward N. Zalta (ed.), 56-62.

Samal J. Fundamental tenets of epidemiology in Ayurveda and their contemporary relevance. Indian J Health Sci Biomed Res [serial online] 2016 [cited 2020 May 17];9:20-6.

Coelho M, Oliveira T, Fernandes R. Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci. 2013;9(2):191‐200. doi:10.5114/aoms.2013.33181

Chan DF, Li AM, Chu WC, Chan MH, Wong EM, Liu EK, Chan IH, Yin J, Lam CW, Fok TF, et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord. 2004 Oct; 28(10):1257-63

Tahaei S, Sedighi N, Derogar R, Aslani A, Malekzadeh R, Merat S. The effect of weight reduction on ultrasonographic findings of nonalcoholic Fatty liver. Middle East J Dig Dis. 2010;2(1):5–8.

Mandal Nisith Kumar,Kundu Suman, JanaDipanjan, Maity Gouranga, Tripathi Joydip: A critical analysis of Meda dhatu: An Approach to Explore the physiological entity, IJAAR VOLUME III ISSUE XI NOV-DEC 2018, 1586-91.

Shastri BS, Vishya RL, editors. Bhavaprakasha of Shri Bhava Mishra, The ‘Vidyotini’ Hindi Commentary, Notes and Appendix. Varanasi: Chaukhambha Sanskrit Sansthan; 1999. p; p. 36-40.

Madhavakra. Medoroganidnam. In: Prof K R Srikantamurthy, translator. MadhavaNidanam. 1sted . Varanasi: ChaukhambhaOrientalia; Reprint 2016. p 121-123.

Alkhouri N, Dixon LJ, Feldstein AE. Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal. Expert Rev Gastroenterol Hepatol. 2009;3(4):445–451. doi:10.1586/egh.09.32

Sonam Agarwal, Vandana Verma, Sangeeta Gehlot; An Exploration on physiology of Vasa, Meda, majja in Ayurveda w.r.s adipose tissue, TANG, 2019, / Volume 9/ Issue 3/ e3

Sastri K, Chaturvedi G; Charka Samhita elaborated Vidyotini hindi commentary, Chaukhambha Bharti academy, Varanasi, reprint 2015, Viman Sthan chapter 5, slok no. 14, page no- 813

Mahesh TS, Shreevidya M. A review on balya action mentioned in Ayurveda. J Ayurveda Integr Med. 2014;5(2):80–84. doi:10.4103/0975-9476.133796

Wensveen FM, Valentić S, Šestan M, Wensveen TT, Polić B. Interactions between adipose tissue and the immune system in health and malnutrition. Semin Immunol.

Kosmalski M, Mokros Ł, Kuna P, Witusik A, Pietras T. Changes in the immune system - the key to diagnostics and therapy of patients with non-alcoholic fatty liver disease. Cent Eur J Immunol. 2018;43(2):231‐239. doi:10.5114/ceji.2018.77395

Immunity in the tissues. Nat Immunol 14, 977 (2013). https://doi.org/10.1038/ni.2722

Aaron R Cox, Natasha Chernis, Peter M Masschelin, Sean M Hartig, Immune Cells Gate White Adipose Tissue Expansion, Endocrinology, Volume 160, Issue 7, July 2019, Pages 1645– 1658, https://doi.org/10.1210/en.2019-00266

Bessone F, Razori MV, Roma MG . Molecular pathways of nonalcoholic fatty liver disease development and progression..Cell Mol Life Sci. 2019 Jan; 76(1):99-128. Epub 2018 Oct 20.

Hamza El Hadi, Roberto Vettor and Marco Rossato. Vitamin E as a Treatment for Nonalcoholic Fatty Liver Disease: Reality or Myth? Antioxidants (Basel). 2018 Jan 16;7(1). pii: E12. doi: 10.3390/antiox7010012.

Buzzetti, E.; Pinzani, M.; Tsochatzis, E.A. The multiplehit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 2016

https://www.wisdomlib.org/definition/yakrimedas

Ueno T, Sugawara H, Sujaku K, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol. 1997;27(1):103‐107.

Vander Windt DJ, Sud V, Zhang H, Tsung A, Huang H. The Effects of Physical Exercise on Fatty Liver Disease. Gene Expr. 2018;18(2):89‐101. doi:10.3727/105221617X15124844266408

Alkhouri N, Dixon LJ, Feldstein AE. Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal. Expert Rev Gastroenterol Hepatol. 2009;3(4):445‐451. doi:10.1586/egh.09.32

Kumari H, Pushpan R, Nishteswar K. Medohara and Lekhaniya dravyas (anti-obesity and hypolipidemic drugs) in Ayurvedic classics: A critical review. Ayu. 2013;34(1):11‐16. doi:10.4103/0974-8520.115437

Xiao J, Fai So K, Liong EC, Tipoe GL. Recent advances in the herbal treatment of non-alcoholic Fatty liver disease. J Tradit Complement Med. 2013;3(2):88‐94.doi:10.4103/2225-4110.110411

Dwivedi S, Chopra D. Revisiting Terminalia arjuna - An Ancient Cardiovascular Drug. J Tradit Complement Med. 2014;4(4):224‐231. doi:10.4103/2225- 4110.139103

Remya E, Mandip Gayal, Non Alcoholic fatty liver diseases – An Ayurvedic pragmatic approach with its Management , Int. J Ayu & her med 7:6(2017) 2948- 2955.